SPDR STOXX Europe 50 (FEU)
| 36.17 Data as of 12:38pm ET |  +0.179 / +0.50%Today’s Change | 27.27 Today|||52-Week Range 36.30 | +7.58% Year-to-Date |
Investment Objective
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the STOXX ® Europe 50 Index. The fund employs a replication strategy, which means that the fund typically invests in substantially all of the securities represented in the index in approximately the same proportions as the index. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index is designed to represent the performance of some of the largest companies across all components of the 20 STOXX Europe 600 Supersector Indexes. It is non-diversified.
Latest FEU News
No recent news for SPDR STOXX Europe 50.
Performance
| 1 month | +6.80% | 3 years | +11.91% | |
| 3 months | +5.15% | 5 years | -2.92% | |
| 1 year | +31.69% | Since inception | +6.84% |
Data through 05/21/2013
Quote Details
| Previous close | $35.99 |
| Open day’s range | 35.80 – 36.17 |
| Net asset value (NAV) | 35.80 (05/20/2013) |
| Daily volume | 2,298 |
| Average volume (3 months) | 12,146 |
Data as of 12:38pm ET, 05/21/2013
Peer Comparisonvs. Europe stock ETFs
| FEU | Category | |
|---|---|---|
| Performance 5-yr return | -2.92% | -4.25% |
| Expense Gross exp ratio | 0.29% | 0.49% |
| Risk 5 year sharpe ratio | -0.01 | -0.02 |
| Net assets | $59.8M | $1.0B |
| Average market cap | $100.8B | $29.3B |
| Average P/E | 14.9 | 14.5 |
| Dividend / Share | -- | 0.59% |
Competitors
Holdings
Top 5 SectorsPortfolio weighting
| Financial service | 27.29% |
| Healthcare | 14.73% |
| Energy | 14.43% |
| Industrial materials | 13.08% |
| Consumer goods | 12.52% |
Top 10 HoldingsPortfolio weighting
| -- Nestle SA | 6.00% |
| -- HSBC Holdings PLC | 5.24% |
| -- Novartis AG | 5.23% |
| -- Roche Holding AG | 4.57% |
| -- Vodafone Group PLC | 3.93% |
| -- BP PLC | 3.58% |
| -- Sanofi | 3.44% |
| -- Royal Dutch Shell PLC Class A | 3.31% |
| -- GlaxoSmithKline PLC | 3.29% |
| -- British American Tobacco PLC | 2.92% |